REXALL SUNDOWN TEST MARKETING "SUNDOWN INFORMATION CENTER"
• By The Tan Sheet
REXALL SUNDOWN TEST MARKETING "SUNDOWN INFORMATION CENTER," a digitalized computer audio box designed to explain to consumers the "workings and uses of vitamins and minerals," the Fort Lauderdale-based company announced in an Aug. 23 press release. The "Sundown Information Center" allows consumers to punch a key pad and a voice explains "in detail" the role of a particular vitamin or mineral supplement in the diet. The device also transmits "intermittent messages about" Rexall's products. Rexall has put together 70 two-minute messages covering 40 of the company's nutritional products. Each message includes information about how a particular product is made, what it contains and the role it plays in a person's diet. A Rexall Sundown spokesperson said that all of the messages have been reviewed by the company's legal counsel and that they are in accordance with FDA's views on the information that can accompany products. Launched in early August in several Florida store sites, Rexall plans to move 10 prototype units into mass merchandisers, supermarkets, drug chains and independents in different regions of the country over the course of the test marketing phase, which is expected to last six months. The product monitors how many times a particular item is queried and the time of day of each query. The information is then matched with store receipts to determine whether a purchase was made. Because the mechanism takes up approximately four-to-six product facings of shelf space, the test marketing phase is evaluating the audio box to determine whether its placement on shelf spaces makes up for potential lost product sales. So far, the company reported that usage of the device has been "dramatic" and that the audio box has enhanced sales. The displays are capable of being equipped with video tubes, Rexall said, and eventually the "Information Center" may include visual interactive devices to accompany the audio portion of the messages. Another marketing tool that the company is currently including as part of its product displays is a built-in magnifier to aid consumers when reading product fine print. Rexall is expecting to complete the purchase of Pennex' Verona, Penn. manufacturing plant by Sept. 30, the company said. The preliminary agreement was announced on Aug. 12 when Pennex filed a Chapter 1 1 petition with the U.S. Bankruptcy Court. At that time, the company said the acquisition would be subject to "satisfactory completion of due diligence reviews, approval of the bankruptcy court and the receipt of any regulatory approvals" ("The Tan Sheet" Aug. 16, p. 19). In the interim, Rexall was interested in reviewing Pennex" customer base before declaring the deal final. The Verona facility will be Rexall Sundown's first manufacturing plant.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
While the first six months of the year saw eight new drugs targeting a range of diseases enter the European Medicines Agency’s priority medicines scheme, and three PRIME-designated treatments go on to win EU marketing approval, use of the accelerated assessment mechanism appears to be limited.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet’s Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.